Batm Advanced Communicat... Share Discussion Threads

[kooba] 16/11/2022 11:21

Echo do return to your fan boy thread..already boring me.For those interested in City Fibre roll out https://www.ispreview.co.uk/index.php/2022/11/numis-report-on-cityfibre-reveals-new-details-of-uk-fttp-broadband-build.html

[echoridge] 16/11/2022 11:13

We can now return to our regularly scheduled programming

[kooba] 16/11/2022 10:50

Thanks..much appreciated ..what it must be to have friends in high places.

[echoridge] 16/11/2022 10:42

I'll let them know

[kooba] 16/11/2022 10:39

Moti Nagar's has 906,200 vested options not yet exercised that have an exercise price of £0.1269..maybe exercise and take them up ..not a lot of money since he took £1m out last option exercise but gets him on the register with a meaningful holding relative to renumeration especially since he is ceo apparent.In terms of tradition BATM has had its primary listing in the UK for over 25 years if they want to see institutional support for the company they need to play by the accepted uk rules of governance.

[echoridge] 16/11/2022 10:35

yes I know, kooba. Good for Zvi and good for us as that alone is a positive that is often forgotten. But Zvi as a founder-entrepreneur type is a bit of a one-off and it hasn't been enough - or he hasn't really bothered - to overcome the Israeli reluctance to do in-market purchases by the execs. As I hinted, I hope Moti changes that philosophy by giving a nod to the UK listing and leads by example.

[kooba] 16/11/2022 10:24

Zvi made frequent purchases despite his already large interest.https://investing.thisismoney.co.uk/director-dealings/BVC

[echoridge] 16/11/2022 10:07

In this particular case, resistance, it would probably help on the margin. One small issue is that there isn't a deep tradition in the Israeli market for executives going in the open market to buy shares (I've also described a parallel situation where the long tradition regarding capital returns in Israel is that institutions there tend to favour re-investment of fcf in favour of capital returns like buybacks, making the latter uncommon). Moti does have a material options holding as I had to point out a few weeks ago, but after all, its main listing is clearing over here and Moti, Ariel, et al, should be encouraged to overcome the inertia caused by Israeli tradition and put their hands in their pockets if and when insider rules are not in effect.

[kooba] 16/11/2022 09:53

I think if he put $100k into the shares it would send a good message and the share price would react favourably.There are times of course where directors cannot deal but close periods and restricted periods normally leave plenty of opportunity. Certainly had the opportunity in the 8 years he has been with the company!Exercising and selling every last share as seen in 2019 should actually be disallowed in my view save for covering tax liabilities executives should have to retain the majority of their share entitlements..and often do in most companies.It's difficult for well paid executives to convince investors of the value in their companies if they will not hold an interest themselves.

[resistance1] 16/11/2022 09:40

Some sense finally from Kooba. Pointing out shareholdings. Yes he should show confidence and buy in. And was there ever a better time to snap up shares or take up options(depending on option prices of course.) There was a time that Director buys gave a good up tick to the share price. Is this still the case? I still know some investors who invest solely upon Directors buys -- they tell me it works for them 70% of the time.

[resistance1] 16/11/2022 09:33

I see from socials that Moti is over early December for the Network Transformation awards in London towards the end of 1st week of December, with Edgility shortlisted for a prize. No doubt he will use to time to meet key institutional investors and gain market confidence for a big push in '23. Bring it on.

[kooba] 16/11/2022 09:02

Batm fall is down to the uk stock market narrative.Ftse 250 ytd down 19%Batm down 62%See how its holding the shares back.

[resistance1] 16/11/2022 08:57

Yesterday saw the news of Paris overtaking London in share value. Paris high on luxury good stars, the FTSE 100 stagnating and the 250 and junior markets moribund to the UKs dismal outlook. BATM of course is being dragged down with it but is a great example of where the UK just plays a minor role in its sales ambitions. The combination of global sales markets in the fastest compound growth sectors. The markets will wake up soon to this jewel in the mud.

[echoridge] 16/11/2022 07:21

I'm a big Moti fan for all the reasons already mentioned. The coming months have multiple known business catalysts that will drive value-creation for BATM and Moti is the right guy to midwife them into financially sound businesses. However, I'm also increasingly of the view that the 1 Jan will begin a process of diminishing the 'Zvi discount' in our share price. I've written before that I believe Israeli institutions are criminally underrepresented on the Company's share register largely because the community there have historically found Zvi - while generally recognising his brilliance at developing groundbreaking products in underdeveloped markets - arrogant, resistant to change, and generally off-putting. I'm highly confident that future marketing efforts in that jurisdiction will find much more receptive audiences and we will begin to see a few more serious institutions build positions. However, in recent weeks I've also begun to think Zvi is the reason that BATM only have the house broker covering the shares. On paper, BATM is the perfect potential research/advisory client for any of the relevant UK broker-dealers. The Company, despite the poor share price performance, is still reasonably sized in the smaller cap universe, the shares are demonstrably cheap and pretty liquid, and best of all of course, the Company has multiple potential corporate actions - from a NASDAQ listing to a spin-off or sale of a major subsidiary like ADOR to multiple capital return possibilities, and these days especially, the possibility of a major acquisition - which would then put any broker already covering/advising the Company in line for a juicy banking fee. This highly appealing backdrop has always made the Company's lack of research coverage particularly frustrating for me, especially as Shore Cap is uniquely useless to begin with. Now I think I understand that that has at least partly been down to Zvi and therefore, with his New Year departure, I fancy the probability that we will soon see more brokers picking up coverage and the low-hanging fruit of eliminating the 'Zvi discount' should begin in earnest.

[kooba] 16/11/2022 06:42

2. Executive Shareholdings and Post-Employment Shareholding RequirementsExecutive directors and senior executives should build up significant holdings in their company's shares. Executives are encouraged to purchase company shares using their own resources in order to provide evidence of their alignment with shareholders. Remuneration Committees should set out the minimum shareholding requirement the executive is expected to meet as well as, the time period in which the executive has to achieve the requirement. The Committee should set out the consequences of an executive not achieving the stated shareholding requirement.https://www.theia.org/sites/default/files/2021-11/Principles%20of%20Remuneration%202022%20-%20Final.pdfBATM 2021 REPORT AND ACCOUNTS"We are also keen to foster a culture of share ownership throughout the Company "Moti Nagar holds no shares in BATM after being in senior executive role for 8 years and has now being promoted to CEO.He has never bought a share with his own resources.He exercised options over 3m in 2019 and sold the lot.09/09/2019 Moti Nagar 3,000,000 @ 46.80p £1,404,000.00 SellAs CFO last year Moti received $475k renumeration as CEO that could move to $1m ( as Zvi received ) next year.Be good to see the company look to the new CEO to join shareholders and make a meaningful investment before assuming the CEO position it might also inspire some confidence for the owners of the business that he is aligned in delivering value to shareholders.

[bigjon1] 15/11/2022 20:26

I agree resistance1, given Moti's background as CFO i'm sure he will have his eyes locked on increasing BATM's profit margins - a perfect fit for the next stage of BATM's development

[resistance1] 15/11/2022 20:19

I feel for the commercialisation phase which BATM is now entering, Moti is our best bet. Allocating appropriate resources to sales and marketing for instance. Zvi clearly was the best CEO for the product development phase. Although R&D will of course continue, the IP already developed must now be ruthlessly exploited.

[bigjon1] 15/11/2022 19:37

for the CEO role leaderships is the most important attribute, the fact one is a scientist and the other is an accountant holds little weight in my eyes. Often you see CEOs who aren't experts in their given industry but the company performs well under their leadership/management

[fse] 15/11/2022 16:43

It’s a wise move to be a paid up member of the service that way you don’t get any thumbs down from the unwashed. I used to be a member for years but I only follow BATM on here now. Not really into the anonymous power of the thumb but to each his own.

[fse] 15/11/2022 16:20

hmmm. I was taking resistance1 advice post 21962

[kooba] 15/11/2022 15:32

You believed that..you believe anything. I'm the only one who actually pays to support this service..I ain't going anywhere. Thanks for the apology though FSE ..glad you are going to be less antagonistic. You talk about me i come back..capeesh.

[resistance1] 15/11/2022 15:19

I don't think there is any need to scold oneself FSE on your self certified unknightly behaviour. You, and we were all provoked, many times. Anyway after Kooba's more positive message of 1st thing this morning, he has (thankfully) 'fallen on his sword' for now. Which fits well with your knight theme...

[fse] 15/11/2022 15:11

There is currently a serious wave of respiratory ailments particularly this time round in younger patients and children. It’s important to quantify just what the source and cause are.

[fse] 15/11/2022 14:22

I feel I would be remiss if I did not apologize for my replies to Kooba and other associated posters. It’s a waste of time and has done the thread no favours. I shall desist henceforth from such un knightly behaviour.

One observation on valuing companies like BATM at this point in its history is that it’s a mistake to expect too much out of sales and subsequent revenue. The company value is largely in its IP potential. The attraction is that they are achieving this without diluting share holder value as they have managed to make sufficient money to pay the bills and progress development.
BATM have a decent war chest and the wherewithal to advance their aspirations.
I mentioned this some time ago but for example I used to be invested in Genmark diagnostics which never made a profit and was sold for @1bn.
There are other examples like that out there. If the company were not making progress I would not be here following them.